Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies

Published on July 16, 2024

Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on ground-breaking research from the MRC Weatherall Institute of Molecular Medicine at University of Oxford.
Continue reading on website
Other news

Oxford University partners with Oxford City F.C.

July 16, 2024
University of Oxford and Oxford City football club have embarked on a long-term partnership which will see the University and the oldest football club in Oxford working closely together across three key areas: education, research and facilities.

University spin-out Oxford Semantic Technologies acquired by Samsung Electronics

July 16, 2024
An Oxford University spinout which supports accurate AI applications using knowledge graph and reasoning technology has been bought by Samsung Electronics.